Overview

Acurastem Inc. is a biotechnology company focused on developing treatments for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). The company is leveraging cutting-edge stem cell and small molecule technologies to address the underlying causes of these conditions.

Therapeutic areas

Neurodegenerative diseasesAmyotrophic lateral sclerosis (ALS)

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Acurastem Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Acurastem Inc.? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.